Assignee
GENTIAN AS
NO·2 granted patents·5 pending applications·0 citations·filing 2017–2023
Top patents by PatentIndex Score
7 records- 0158US2023384296A1Highly sensitive particle enhanced assay for the quantification of nt-probnpGENTIAN AS·Filed 2023·Application pending·0 cites
- 0256US11609230B2Highly sensitive particle enhanced assay for the quantification of NT-proBNPGENTIAN AS·Filed 2021·Granted Mar 21, 2023·0 cites·10 claims
- 0343US2025271451A1Novel method for determining a concentration of n-terminal pro-hormone bnp (nt-probnp) in a sampleGENTIAN AS·Filed 2022·Application pending·0 cites
- 0442US12578330B2Methods for determining the concentration of an analyte in the plasma fraction of a sample of whole bloodGENTIAN AS·Filed 2021·Granted Mar 17, 2026·0 cites·15 claims
- 0539US2023296602A1Assay method, kit, and reagents for quantitative determination of antibodies against selected virusesGENTIAN AS·Filed 2021·Application pending·0 cites
- 0638US2019232286A1Assay Device and Method for Assessing Blood CellsGENTIAN AS·Filed 2017·Application pending·0 cites
- 0735US2022074956A1Methods for determining the hematocrit level in a sample of whole bloodGENTIAN AS·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENTIAN AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →